Pivotal Clinic Study of the H-TTS



Status:Recruiting
Conditions:Other Indications, Infectious Disease, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Other
Healthy:No
Age Range:Any - 12
Updated:3/22/2019
Start Date:July 24, 2018
End Date:December 31, 2019
Contact:Nicole LaSota, BA
Email:clinical@preceptismedical.com
Phone:612-900-5441

Use our guide to learn which trials are right for you!

Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic: A Non-Significant Risk Study

The objective of this study is to evaluate the safety and performance of the H-TTS for the
placement of ear tubes in patients undergoing tympanostomy tube placement in an
otolaryngology clinic using local anesthetic.

The H-TTS is indicated for patients undergoing a tympanostomy tube procedure. The H-TTS is
intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a
tympanostomy procedure.

The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to
deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a
tympanostomy tube placement procedure. More than 1,000,000 ear tubes are inserted annually in
the US, making it one of the most common surgical procedures performed in children. Most ear
tubes are inserted by otolaryngologists using either local anesthesia (usually adults) or
general anesthesia (usually children).

Preceptis Medical, Inc. has developed the H-TTS to reduce trauma, pain, and risk to the
patient while reducing the overall surgical procedure time. The H-TTS integrates the multiple
surgical instruments necessary for current surgical procedure into a single, one-pass device.
The H-TTS creates an incision in the tympanic membrane ("ear drum") and inserts a
tympanostomy tube with the push of a lever. Thus, the H-TTS allows placement of a
tympanostomy tube with a single pass down the ear canal. The ear tube used with the H-TTS is
a standard, commercially available tympanostomy tube. The H-TTS has been cleared by the FDA
for use in a hospital or ASC setting under both general anesthesia and moderate (conscious)
sedation.

The study will be a multi-site, prospective, treatment-only study of the H-TTS. Enrollment in
the study at each site will begin after receipt of Institutional Review Board (IRB) approval.
50 to 200 patients will be included at 3-10 clinical sites.

Inclusion Criteria:

- Scheduled to undergo tympanostomy tube insertion in the clinic.

- Ages ≥6 months through ≤24 months or ≥5 years through ≤12 years.

- Signed parental consent, and child assent documents as applicable.

- Parent is fluent in English.

Exclusion Criteria:

- Any condition that, in the opinion of the investigator, may place the subject at
greater risk (e.g., child with developmental delay).

- Anatomy precludes sufficient visualization and access to the tympanic membrane.
We found this trial at
9
sites
Saint Cloud, Minnesota 56303
Principal Investigator: Theodore Truitt, MD
Phone: 320-204-5887
?
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Beverly Hills, California 90211
Principal Investigator: Gene Liu, MD
Phone: 310-423-1220
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Bismarck, North Dakota 58503
Principal Investigator: Jay Raisen, MD
Phone: 701-805-8057
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Bloomington, Minnesota 55425
Principal Investigator: Chris Hilton, MD
Phone: 651-254-5303
?
mi
from
Bloomington, MN
Click here to add this to my saved trials
Grand Forks, North Dakota 58201
Principal Investigator: Alan Johnson, MD
Phone: 701-780-1845
?
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Jacksonville, Florida 32257
Principal Investigator: Daniel Wohl, MD
Phone: 904-262-7368
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Orlando, Florida 32835
Principal Investigator: James Kosko, MD
Phone: 407-253-1000
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Shelagh Cofer, MD
Phone: 507-538-1392
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Louis Park, Minnesota 55426
Principal Investigator: Sandra Skovlund, MD
Phone: 651-254-5303
?
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials